These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2065704)

  • 1. Evaluation of bioequivalence studies.
    Grieve AP
    Eur J Clin Pharmacol; 1991; 40(2):201-3. PubMed ID: 2065704
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparison of the results obtained using the test of hypothesis, confidence intervals, and Bayesian analysis in the evaluation of bioequivalence].
    Ohki T; Ueda Y; Suzuki T
    Yakugaku Zasshi; 1985 Aug; 105(8):796-800. PubMed ID: 4087155
    [No Abstract]   [Full Text] [Related]  

  • 3. A semi-parametric Bayesian approach to average bioequivalence.
    Ghosh P; Rosner GL
    Stat Med; 2007 Mar; 26(6):1224-36. PubMed ID: 16832840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bayesian approach to average bioequivalence using Bayes' factor.
    Ghosh P; Khattree R
    J Biopharm Stat; 2003 Nov; 13(4):719-34. PubMed ID: 14584718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bayesian modeling of multivariate average bioequivalence.
    Ghosh P; Gönen M
    Stat Med; 2008 Jun; 27(13):2402-19. PubMed ID: 18095275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of Bayesian methods for multivariate bioequivalence measures.
    Molina de Souza R; Achcar JA; Martinez EZ
    J Biopharm Stat; 2009; 19(1):42-66. PubMed ID: 19127466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bayesian approach to bioequivalence assessment: an example.
    Fluehler H; Grieve AP; Mandallaz D; Mau J; Moser HA
    J Pharm Sci; 1983 Oct; 72(10):1178-81. PubMed ID: 6644568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On Bayesian Analysis and Hypothesis Testing in the Determination of Bioequivalence.
    Schuirmann DJ; Grosser S; Chattopadhyay S; Chow SC
    Clin Pharmacol Ther; 2019 Feb; 105(2):304-306. PubMed ID: 30666636
    [No Abstract]   [Full Text] [Related]  

  • 9. A Bayesian approach to bioequivalence for the 2 x 2 changeover design.
    Selwyn MR; Dempster AP; Hall NR
    Biometrics; 1981 Mar; 37(1):11-21. PubMed ID: 7018605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of outlying subjects on decision of bioequivalence.
    Ki FY; Liu JP; Wang W; Chow SC
    J Biopharm Stat; 1995 Mar; 5(1):71-94. PubMed ID: 7613561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of asymmetric distributions in average bioequivalence.
    de Souza RM; Achcar JA; Martinez EZ; Mazucheli J
    Stat Med; 2016 Jul; 35(15):2525-42. PubMed ID: 26840012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new statistical procedure of interval hypothesis testing for bioequivalence studies.
    Ohki T; Suzuki T; Goto S
    Biol Pharm Bull; 1995 Jan; 18(1):192-4. PubMed ID: 7735242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Joint equivalence of means and variances of two populations.
    Grieve AP
    J Biopharm Stat; 1998 Jul; 8(3):377-90. PubMed ID: 9741854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The transitivity of bioequivalence testing: potential for drift.
    Anderson S; Hauck WW
    Int J Clin Pharmacol Ther; 1996 Sep; 34(9):369-74. PubMed ID: 8880284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multivariate test for population bioequivalence.
    Chervoneva I; Hyslop T; Hauck WW
    Stat Med; 2007 Mar; 26(6):1208-23. PubMed ID: 16810712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Report supports FDA's bioequivalence evaluation criteria, advocates more stringent statistical testing.
    Clin Pharm; 1988 May; 7(5):334,7. PubMed ID: 3383540
    [No Abstract]   [Full Text] [Related]  

  • 17. Update on the statistical analysis of bioequivalence studies.
    Steinijans VW; Hauschke D
    Int J Clin Pharmacol Ther Toxicol; 1992; 30 Suppl 1():S45-50. PubMed ID: 1601531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Types of bioequivalence and related statistical considerations.
    Hauck WW; Anderson S
    Int J Clin Pharmacol Ther Toxicol; 1992 May; 30(5):181-7. PubMed ID: 1592546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discussion of individual bioequivalence by M.-L. Chen.
    Gould AL
    J Biopharm Stat; 1997 Mar; 7(1):23-9. PubMed ID: 9056584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A group sequential approach to crossover trials for average bioequivalence.
    Hauck WW; Preston PE; Bois FY
    J Biopharm Stat; 1997 Mar; 7(1):87-96. PubMed ID: 9056590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.